Article Text

Download PDFPDF

Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Liao et al
  1. Sylvain Mathieu,
  2. Martin Soubrier
  1. 1 Rheumatology, Clermont University, CHU Gabriel-Montpied, Clermont-Ferrand, France
  1. Correspondence to Dr Sylvain Mathieu, Rheumatology, Clermont University, CHU Gabriel-Montpied, Clermont-Ferrand, France; smathieu{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We would like to thank Liao and colleagues for their attention to our study1 and for the results of their nationwide cohort study reporting a higher incidence of diabetes mellitus in ankylosing spondylitis (AS).2

In our study, we did not assess the cardiovascular risk profile or evaluate the incidence of diabetes mellitus among AS patients. We completely agree that there might be a relationship between a higher incidence of diabetes and the increased risk of cardiovascular events found in AS patients. Assessment of AS patients should include examination for the presence of diabetes mellitus. As stated by Liao and colleagues, additional studies are needed to draw strong conclusions regarding the association between diabetes and AS.

Ethics statements



  • Handling editor Josef S Smolen

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Correspondence
    Kuan-Fu Liao Yu-Hung Kuo Shih-Wei Lai